The Female Health Company (NASDAQ: FHCO) produces and markets the FC2 Female Condom® (FC2). The company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in a number of countries that cover key aspects of FC2 like its overall design and production process. The FC2 Female Condom® is the only female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy available. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies. For more information, visit the company’s website at www.femalehealth.com